RYK knockdown in glioma cells suppressed matrix metalloproteinase-2 (MMP2) and Wnt5a-induced invasion [127], suggesting RYK can regulate extracellular matrix degradation and tumor invasive capacity. The gene discussed is RYK; the disease is central nervous system cancer.